{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T11:00:06Z","timestamp":1760785206266,"version":"3.40.4"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2024,11,19]],"date-time":"2024-11-19T00:00:00Z","timestamp":1731974400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,11,19]],"date-time":"2024-11-19T00:00:00Z","timestamp":1731974400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100014718","name":"Innovative Research Group Project of the National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82202248"],"award-info":[{"award-number":["82202248"]}],"id":[{"id":"10.13039\/100014718","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018542","name":"Natural Science Foundation of Sichuan Province","doi-asserted-by":"publisher","award":["23NSFSC4589"],"award-info":[{"award-number":["23NSFSC4589"]}],"id":[{"id":"10.13039\/501100018542","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013365","name":"West China Hospital, Sichuan University","doi-asserted-by":"publisher","award":["23HXFH041"],"award-info":[{"award-number":["23HXFH041"]}],"id":[{"id":"10.13039\/501100013365","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur Radiol"],"DOI":"10.1007\/s00330-024-11203-7","type":"journal-article","created":{"date-parts":[[2024,11,19]],"date-time":"2024-11-19T21:43:09Z","timestamp":1732052589000},"page":"2888-2898","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Screening for Fabry disease in patients with hypertrophic cardiomyopathy using cardiac magnetic resonance imaging"],"prefix":"10.1007","volume":"35","author":[{"given":"Jialin","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lutong","family":"Pu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ziqian","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ke","family":"Wan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuanwei","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jie","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuchi","family":"Han","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8480-4054","authenticated-orcid":false,"given":"Yucheng","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,11,19]]},"reference":[{"key":"11203_CR1","doi-asserted-by":"crossref","unstructured":"Aquaro GD, De Gori C, Faggioni L et al (2022) Cardiac magnetic resonance in Fabry disease: morphological, functional, and tissue features. Diagnostics 12:2652","DOI":"10.3390\/diagnostics12112652"},{"key":"11203_CR2","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1016\/j.acvd.2019.01.002","volume":"112","author":"A Hag\u00e8ge","year":"2019","unstructured":"Hag\u00e8ge A, R\u00e9ant P, Habib G et al (2019) Fabry disease in cardiology practice: literature review and expert point of view. Arch Cardiovasc Dis 112:278\u2013287","journal-title":"Arch Cardiovasc Dis"},{"key":"11203_CR3","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1007\/s12551-018-0432-5","volume":"10","author":"MM Akhtar","year":"2018","unstructured":"Akhtar MM, Elliott PM (2018) Anderson-Fabry disease in heart failure. Biophys Rev 10:1107\u20131119","journal-title":"Biophys Rev"},{"key":"11203_CR4","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.2147\/DDDT.S365885","volume":"18","author":"S Feriozzi","year":"2024","unstructured":"Feriozzi S, Chimenti C, Reisin RC (2024) Updated evaluation of agalsidase alfa enzyme replacement therapy for patients with Fabry disease: insights from real-world data. Drug Des, Dev Ther 18:1083\u20131101","journal-title":"Drug Des, Dev Ther"},{"key":"11203_CR5","doi-asserted-by":"publisher","first-page":"e032734","DOI":"10.1161\/JAHA.123.032734","volume":"13","author":"A Frustaci","year":"2024","unstructured":"Frustaci A, Verardo R, Galea N et al (2024) Long-term clinical-pathologic results of enzyme replacement therapy in prehypertrophic Fabry disease cardiomyopathy. J Am Heart Assoc 13:e032734","journal-title":"J Am Heart Assoc"},{"key":"11203_CR6","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1016\/j.pcad.2009.11.002","volume":"52","author":"C O\u2019Mahony","year":"2010","unstructured":"O\u2019Mahony C, Elliott P (2010) Anderson-Fabry disease and the heart. Prog Cardiovasc Dis 52:326\u2013335","journal-title":"Prog Cardiovasc Dis"},{"key":"11203_CR7","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1016\/j.jacc.2010.11.018","volume":"57","author":"MR Patel","year":"2011","unstructured":"Patel MR, Cecchi F, Cizmarik M et al (2011) Cardiovascular events in patients with Fabry disease natural history data from the Fabry registry. J Am Coll Cardiol 57:1093\u20131099","journal-title":"J Am Coll Cardiol"},{"key":"11203_CR8","doi-asserted-by":"publisher","first-page":"4557","DOI":"10.1007\/s00330-020-07650-7","volume":"31","author":"Y Li","year":"2021","unstructured":"Li Y, Liu X, Yang F et al (2021) Prognostic value of myocardial extracellular volume fraction evaluation based on cardiac magnetic resonance T1 mapping with T1 long and short in hypertrophic cardiomyopathy. Eur Radiol 31:4557\u20134567","journal-title":"Eur Radiol"},{"key":"11203_CR9","first-page":"e558","volume":"142","author":"SR Ommen","year":"2020","unstructured":"Ommen SR, Mital S, Burke MA et al (2020) 2020 AHA\/ACC guideline for the diagnosis and treatment of patients with hypertrophic cardiomyopathy: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation 142:e558\u2013e631","journal-title":"Circulation"},{"key":"11203_CR10","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1007\/s00330-022-09020-x","volume":"33","author":"L Pu","year":"2023","unstructured":"Pu L, Diao Y, Wang J et al (2023) The predictive value of fast semi-automated left atrial long-axis strain analysis for atrial fibrillation in hypertrophic cardiomyopathy. Eur Radiol 33:312\u2013320","journal-title":"Eur Radiol"},{"key":"11203_CR11","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1148\/radiol.2018172613","volume":"288","author":"GR Karur","year":"2018","unstructured":"Karur GR, Robison S, Iwanochko RM et al (2018) Use of myocardial T1 mapping at 3.0 T to differentiate Anderson-Fabry disease from hypertrophic cardiomyopathy. Radiology 288:398\u2013406","journal-title":"Radiology"},{"key":"11203_CR12","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.jjcc.2019.09.002","volume":"75","author":"A Nojiri","year":"2020","unstructured":"Nojiri A, Anan I, Morimoto S et al (2020) Clinical findings of gadolinium-enhanced cardiac magnetic resonance in Fabry patients. J Cardiol 75:27\u201333","journal-title":"J Cardiol"},{"key":"11203_CR13","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1536\/ihj.18-167","volume":"60","author":"J Wang","year":"2019","unstructured":"Wang J, Li W, Han Y, Chen Y (2019) Different clinical presentation and tissue characterization in a monozygotic twin pair with MYH7 mutation-related hypertrophic cardiomyopathy. Int Heart J 60:477\u2013481","journal-title":"Int Heart J"},{"key":"11203_CR14","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/s12968-019-0590-z","volume":"22","author":"Y-D Liang","year":"2020","unstructured":"Liang Y-D, Xu Y-W, Li W-H et al (2020) Left ventricular function recovery in peripartum cardiomyopathy: a cardiovascular magnetic resonance study by myocardial T1 and T2 mapping. J Cardiovasc Magn Reson 22:2","journal-title":"J Cardiovasc Magn Reson"},{"key":"11203_CR15","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1016\/j.jcmg.2012.03.011","volume":"5","author":"A Florian","year":"2012","unstructured":"Florian A, Masci PG, De Buck S et al (2012) Geometric assessment of asymmetric septal hypertrophic cardiomyopathy by CMR. JACC Cardiovasc Imaging 5:702\u2013711","journal-title":"JACC Cardiovasc Imaging"},{"key":"11203_CR16","doi-asserted-by":"publisher","first-page":"4364279","DOI":"10.1155\/2022\/4364279","volume":"2022","author":"H Liu","year":"2022","unstructured":"Liu H, Bai P, Xu H-Y et al (2022) Distinguishing cardiac amyloidosis and hypertrophic cardiomyopathy by thickness and myocardial deformation of the right ventricle. Cardiol Res Pract 2022:4364279","journal-title":"Cardiol Res Pract"},{"key":"11203_CR17","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.ijcard.2019.08.010","volume":"294","author":"F Yang","year":"2019","unstructured":"Yang F, Wang J, Li Y et al (2019) The prognostic value of biventricular long axis strain using standard cardiovascular magnetic resonance imaging in patients with hypertrophic cardiomyopathy. Int J Cardiol 294:43\u201349","journal-title":"Int J Cardiol"},{"key":"11203_CR18","volume":"22","author":"T Sawada","year":"2020","unstructured":"Sawada T, Kido J, Yoshida S et al (2020) Newborn screening for Fabry disease in the western region of Japan. Mol Genet Metab Rep. 22:100562","journal-title":"Mol Genet Metab Rep."},{"key":"11203_CR19","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1016\/j.tcm.2017.10.001","volume":"28","author":"T-R Hsu","year":"2018","unstructured":"Hsu T-R, Niu D-M (2018) Fabry disease: review and experience during newborn screening. Trends Cardiovasc Med 28:274\u2013281","journal-title":"Trends Cardiovasc Med"},{"key":"11203_CR20","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/S0140-6736(11)61266-X","volume":"379","author":"TP Mechtler","year":"2012","unstructured":"Mechtler TP, Stary S, Metz TF et al (2012) Neonatal screening for lysosomal storage disorders: feasibility and incidence from a nationwide study in Austria. Lancet 379:335\u2013341","journal-title":"Lancet"},{"key":"11203_CR21","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1093\/ndt\/gfaa324","volume":"37","author":"A Nagata","year":"2021","unstructured":"Nagata A, Nasu M, Kaida Y et al (2021) Screening of Fabry disease in patients with chronic kidney disease in Japan. Nephrol Dial Transplant 37:115\u2013125","journal-title":"Nephrol Dial Transplant"},{"key":"11203_CR22","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1111\/j.1399-0004.2009.01166.x","volume":"76","author":"YL Lv","year":"2009","unstructured":"Lv YL, Wang WM, Pan XX et al (2009) A successful screening for Fabry disease in a Chinese dialysis patient population. Clin Genet 76:219\u2013221","journal-title":"Clin Genet"},{"key":"11203_CR23","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1136\/jmedgenet-2017-105080","volume":"55","author":"D Doheny","year":"2018","unstructured":"Doheny D, Srinivasan R, Pagant S, Chen B, Yasuda M, Desnick RJ (2018) Fabry disease: prevalence of affected males and heterozygotes with pathogenic GLA mutations identified by screening renal, cardiac and stroke clinics, 1995\u20132017. J Med Genet 55:261\u2013268","journal-title":"J Med Genet"},{"key":"11203_CR24","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1016\/j.amjms.2021.01.009","volume":"362","author":"Y Xiao","year":"2021","unstructured":"Xiao Y, Sun Y, Tian T et al (2021) Prevalence and clinical characteristics of Fabry disease in Chinese patients with hypertrophic cardiomyopathy. Am J Med Sci 362:260\u2013267","journal-title":"Am J Med Sci"},{"key":"11203_CR25","doi-asserted-by":"crossref","unstructured":"Ponsiglione A, De Giorgi M, Ascione R et al (2023) Advanced CMR techniques in Anderson-Fabry disease: state of the art. Diagnostics 13:2598","DOI":"10.3390\/diagnostics13152598"},{"key":"11203_CR26","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1148\/radiol.220067","volume":"305","author":"W Warnica","year":"2022","unstructured":"Warnica W, Al-Arnawoot A, Stanimirovic A et al (2022) Clinical impact of cardiac MRI T1 and T2 parametric mapping in patients with suspected cardiomyopathy. Radiology 305:319\u2013326","journal-title":"Radiology"},{"key":"11203_CR27","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/s12968-022-00859-z","volume":"24","author":"A Ponsiglione","year":"2022","unstructured":"Ponsiglione A, Gambardella M, Green R et al (2022) Cardiovascular magnetic resonance native T1 mapping in Anderson-Fabry disease: a systematic review and meta-analysis. J Cardiovasc Magn Reson 24:31","journal-title":"J Cardiovasc Magn Reson"},{"key":"11203_CR28","doi-asserted-by":"publisher","first-page":"e009430","DOI":"10.1161\/CIRCIMAGING.119.009430","volume":"12","author":"S Nordin","year":"2019","unstructured":"Nordin S, Kozor R, Vijapurapu R et al (2019) Myocardial storage, inflammation, and cardiac phenotype in Fabry disease after one year of enzyme replacement therapy. Circ Cardiovasc Imaging 12:e009430","journal-title":"Circ Cardiovasc Imaging"},{"key":"11203_CR29","doi-asserted-by":"publisher","first-page":"e010171","DOI":"10.1161\/CIRCIMAGING.119.010171","volume":"13","author":"JB Augusto","year":"2020","unstructured":"Augusto JB, Nordin S, Vijapurapu R et al (2020) Myocardial edema, myocyte injury, and disease severity in Fabry disease. Circ Cardiovasc Imaging 13:e010171","journal-title":"Circ Cardiovasc Imaging"},{"key":"11203_CR30","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1136\/heartjnl-2018-313699","volume":"105","author":"R Vijapurapu","year":"2019","unstructured":"Vijapurapu R, Nordin S, Baig S et al (2019) Global longitudinal strain, myocardial storage and hypertrophy in Fabry disease. Heart 105:470\u2013476","journal-title":"Heart"},{"key":"11203_CR31","doi-asserted-by":"publisher","first-page":"2039","DOI":"10.1007\/s00330-022-09183-7","volume":"33","author":"MC Halfmann","year":"2023","unstructured":"Halfmann MC, Altmann S, Schoepf UJ et al (2023) Left atrial strain correlates with severity of cardiac involvement in Anderson-Fabry disease. Eur Radiol 33:2039\u20132051","journal-title":"Eur Radiol"},{"key":"11203_CR32","doi-asserted-by":"publisher","first-page":"110471","DOI":"10.1016\/j.ejrad.2022.110471","volume":"155","author":"MC Halfmann","year":"2022","unstructured":"Halfmann MC, Benz S, Schoepf UJ et al (2022) Biventricular strain assessment indicates progressive impairment of myocardial contractility in phenotypically negative patients with Fabry\u2019s disease. Eur J Radiol 155:110471","journal-title":"Eur J Radiol"},{"key":"11203_CR33","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-023-32464-0","volume":"13","author":"M Avanesov","year":"2023","unstructured":"Avanesov M, Asgari A, Muschol N et al (2023) Comparison of classical Fabry and its p.D313Y and p.A143T variants by cardiac T1 mapping, LGE and feature tracking myocardial strain. Sci Rep 13:5809","journal-title":"Sci Rep"},{"key":"11203_CR34","doi-asserted-by":"publisher","first-page":"1673","DOI":"10.1016\/j.jcmg.2018.03.020","volume":"12","author":"S Nordin","year":"2019","unstructured":"Nordin S, Kozor R, Medina-Menacho K et al (2019) Proposed stages of myocardial phenotype development in Fabry disease. JACC Cardiovasc Imaging 12:1673\u20131683","journal-title":"JACC Cardiovasc Imaging"},{"key":"11203_CR35","doi-asserted-by":"publisher","first-page":"1230","DOI":"10.1016\/j.jcmg.2018.11.039","volume":"12","author":"R Perry","year":"2019","unstructured":"Perry R, Shah R, Saiedi M et al (2019) The role of cardiac imaging in the diagnosis and management of Anderson-Fabry disease. JACC Cardiovasc Imaging 12:1230\u20131242","journal-title":"JACC Cardiovasc Imaging"},{"key":"11203_CR36","doi-asserted-by":"publisher","first-page":"140","DOI":"10.3389\/fphys.2018.00140","volume":"9","author":"Y Dong","year":"2018","unstructured":"Dong Y, Yang D, Han Y et al (2018) Age and gender impact the measurement of myocardial interstitial fibrosis in a healthy adult Chinese population: a cardiac magnetic resonance study. Front Physiol 9:140","journal-title":"Front Physiol"}],"container-title":["European Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00330-024-11203-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00330-024-11203-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00330-024-11203-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,24]],"date-time":"2025-04-24T11:05:50Z","timestamp":1745492750000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00330-024-11203-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,19]]},"references-count":36,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2025,5]]}},"alternative-id":["11203"],"URL":"https:\/\/doi.org\/10.1007\/s00330-024-11203-7","relation":{},"ISSN":["1432-1084"],"issn-type":[{"type":"electronic","value":"1432-1084"}],"subject":[],"published":{"date-parts":[[2024,11,19]]},"assertion":[{"value":"5 June 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 August 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 October 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 November 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The scientific guarantor of this publication is Yucheng Chen, MD, FACC, FSCMR, Professor, Department of Cardiology, West China Hospital, Sichuan University, Guoxue Xiang No. 37, Chengdu, Sichuan Province 610041, P. R. China.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Guarantor"}},{"value":"The authors of this manuscript declare no relationships with any companies, whose products or services may be related to the subject matter of the article.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"No complex statistical methods were necessary for this paper.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Statistics and biometry"}},{"value":"Written informed consent was obtained from all subjects (patients) in this study.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"Institutional Review Board approval was obtained.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"No study subjects or cohorts have been previously reported.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Study subjects or cohorts overlap"}},{"order":8,"name":"Ethics","group":{"name":"EthicsHeading","label":"Methodology"}}]}}